Gene therapy thwarts hepatitis C in mice

Gene therapy that induces infected liver cells to self-destruct slows hepatitis C dramatically in mice, scientists report.

Christopher D. Richardson of the Ontario Cancer Institute in Toronto and his colleagues implanted human liver cells into mice and infected the animals with the hepatitis C virus. The researchers then gave the mice three injections.